BIOR
Price
$2.20
Change
+$0.03 (+1.38%)
Updated
Oct 2, 6:59 PM EST
FATE
Price
$1.92
Change
-$0.20 (-9.43%)
Updated
Oct 2, 6:59 PM EST
31 days until earnings call

Compare trend and price BIOR vs FATE

Header iconBIOR vs FATE Comparison
Open Charts BIOR vs FATEBanner chart's image
Biora Therapeutics
Price$2.20
Change+$0.03 (+1.38%)
Volume$97.57K
CapitalizationN/A
Fate Therapeutics
Price$1.92
Change-$0.20 (-9.43%)
Volume$788.92K
CapitalizationN/A
View a ticker or compare two or three
BIOR vs FATE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
BIOR vs. FATE commentary
Oct 02, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOR is a Hold and FATE is a Sell.

COMPARISON
Comparison
Oct 02, 2023
Stock price -- (BIOR: $2.17 vs. FATE: $2.13)
Brand notoriety: BIOR and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BIOR: 35% vs. FATE: 48%
Market capitalization -- BIOR: $49.92M vs. FATE: $214.87M
BIOR [@Biotechnology] is valued at $49.92M. FATE’s [@Biotechnology] market capitalization is $214.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $410.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOR’s FA Score shows that 0 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • BIOR’s FA Score: 0 green, 5 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, FATE is a better buy in the long-term than BIOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOR’s TA Score shows that 5 TA indicator(s) are bullish while FATE’s TA Score has 5 bullish TA indicator(s).

  • BIOR’s TA Score: 5 bullish, 3 bearish.
  • FATE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both BIOR and FATE are a good buy in the short-term.

Price Growth

BIOR (@Biotechnology) experienced а +1.88% price change this week, while FATE (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.39%. For the same industry, the average monthly price growth was +18.43%, and the average quarterly price growth was +21.40%.

Reported Earning Dates

BIOR is expected to report earnings on May 15, 2023.

FATE is expected to report earnings on Nov 02, 2023.

Industries' Descriptions

@Biotechnology (+0.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BIOR with price predictions.
OPEN
A.I.dvisor published
a Summary for FATE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FATE($215M) has a higher market cap than BIOR($49.9M). BIOR YTD gains are higher at: -34.093 vs. FATE (-78.890). BIOR has higher annual earnings (EBITDA): -51.66M vs. FATE (-225.28M). FATE has more cash in the bank: 378M vs. BIOR (26.5M). FATE has less debt than BIOR: FATE (106M) vs BIOR (131M). FATE has higher revenues than BIOR: FATE (119M) vs BIOR (98K).
BIORFATEBIOR / FATE
Capitalization49.9M215M23%
EBITDA-51.66M-225.28M23%
Gain YTD-34.093-78.89043%
P/E RatioN/AN/A-
Revenue98K119M0%
Total Cash26.5M378M7%
Total Debt131M106M124%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
53
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BIORFATE
RSI
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
86%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
MACD
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 5 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 7 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BILI13.770.25
+1.85%
Bilibili
EPOW1.910.01
+0.53%
Sunrise New Energy Co Ltd
KO55.980.17
+0.30%
Coca-Cola Company
CVRX15.17-0.01
-0.07%
CVRx
SPHR37.16-0.48
-1.28%
Sphere Entertainment Co

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been closely correlated with GRPH. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if FATE jumps, then GRPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.29%
GRPH - FATE
69%
Closely correlated
+4.22%
ATAI - FATE
54%
Loosely correlated
-1.15%
NBRVF - FATE
53%
Loosely correlated
+7.14%
CVAC - FATE
52%
Loosely correlated
+5.08%
OCUL - FATE
51%
Loosely correlated
-1.57%
More